Patents by Inventor Irina Gennadievna VASILYEVA

Irina Gennadievna VASILYEVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, Crohn's disease, adenomyosis, and hyperplastic diseases of the prostate gland
    Patent number: 9308270
    Abstract: The invention relates to pharmacy. It is an object of the present invention to produce nanomicellar structures containing EGCG and achieving a positive result consisting in increasing bioavailability in peroral administration. The object of this invention is achieved by a new pharmaceutical composition for peroral administration containing epigallocatechin-3-gallate as the active component and a target additive that is a block copolymer of oxyethylene and oxypropylene, in which the content of the hydrophobic block is less than 50% by mass and the hydrophilic block has a molecular weight of 2,250 daltons or more at a ratio of the block copolymer to the active component ranging from 1:1 to 10:1. The composition improves absorption of the active compound by the blood flow when delivered perorally.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: April 12, 2016
    Assignee: NORDIC LABS LIMITED
    Inventors: Vsevolod Ivanovich Kiselev, Irina Gennadievna Vasilyeva
  • PHARMACEUTICAL COMPOSITION ON THE BASIS OF NANOMICELLES CONTAINING EPIGALLOCATECHIN GALLATE AND A METHOD OF ADMINISTRATION THEREOF TO TREAT ATOPIC DERMATITIS, CROHN'S DISEASE, ADENOMYOSIS, AND HYPERPLASTIC DISEASES OF THE PROSTATE GLAND
    Publication number: 20140235708
    Abstract: The invention relates to pharmacy. It is an object of the present invention to produce nanomicellar structures containing EGCG and achieving a positive result consisting in increasing bioavailability in peroral administration. The object of this invention is achieved by a new pharmaceutical composition for peroral administration containing epigallocatechin-3-gallate as the active component and a target additive that is a block copolymer of oxyethylene and oxypropylene, in which the content of the hydrophobic block is less than 50% by mass and the hydrophilic block has a molecular weight of 2,250 daltons or more at a ratio of the block copolymer to the active component ranging from 1:1 to 10:1. The composition improves absorption of the active compound by the blood flow when delivered perorally.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Inventors: Vsevolod Ivanovich KISELEV, Irina Gennadievna VASILYEVA